UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 35

Sortiert nach

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)

PloS one, 2017-01, Vol.12 (1), p.e0169533-e0169533

2017

Link zum Volltext

Verfügbarkeit prüfen

A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types

PloS one, 2015-03, Vol.10 (3), p.e0120152-e0120152

2015

Link zum Volltext

Verfügbarkeit prüfen

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

PloS one, 2015-09, Vol.10 (9), p.e0138722-e0138722

2015

Link zum Volltext

Verfügbarkeit prüfen

Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions

Cancer epidemiology, biomarkers & prevention, 2008-01, Vol.17 (1), p.189-195

2008

Link zum Volltext

Verfügbarkeit prüfen

Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot study

BMC research notes, 2014-07, Vol.7 (1), p.445-445, Article 445

2014

Link zum Volltext

Verfügbarkeit prüfen

Developments in L2-based human papillomavirus (HPV) vaccines

Virus research, 2017-03, Vol.231, p.166-175

2017

Link zum Volltext

Verfügbarkeit prüfen

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer

Journal of virology, 2022-07, Vol.96 (13), p.e0056622-e0056622

2022

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses

Journal of investigative dermatology, 2013-12, Vol.133 (12), p.2706-2713

2013

Link zum Volltext

Verfügbarkeit prüfen

Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model

Vaccine, 2023-07, Vol.41 (31), p.4480-4487

2023

Link zum Volltext

Verfügbarkeit prüfen

Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors

Virology (New York, N.Y.), 2015-12, Vol.486, p.284-290

2015

Link zum Volltext

Verfügbarkeit prüfen

Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine

Nanomedicine, 2021-04, Vol.33, p.102359-102359, Article 102359

2021

Link zum Volltext

Verfügbarkeit prüfen

Cutaneous Human Papillomaviruses Found in Sun-Exposed Skin: Beta-papillomavirus Species 2 Predominates in Squamous Cell Carcinoma

The Journal of infectious diseases, 2007-09, Vol.196 (6), p.876-883

2007

Link zum Volltext

Verfügbarkeit prüfen

Anogenital Human Papillomavirus Prevalence is Unaffected by Therapeutic Tumour Necrosis Factor-alpha Inhibition

Acta dermato-venereologica, 2016-01, Vol.96 (4), p.494-498

2016

Link zum Volltext

Verfügbarkeit prüfen

High Prevalence of Cutaneous Human Papillomavirus DNA on the Top of Skin Tumors but not in “Stripped” Biopsies from the Same Tumors

Journal of investigative dermatology, 2004-08, Vol.123 (2), p.388-394

2004

Link zum Volltext

Verfügbarkeit prüfen

A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome

Vaccine, 2010-07, Vol.28 (30), p.4837-4841

2010

Link zum Volltext

Verfügbarkeit prüfen

Differences in incidence and co‐occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

International journal of cancer, 2011-03, Vol.128 (5), p.1114-1119

2011

Link zum Volltext

Verfügbarkeit prüfen

Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile‐aged Finnish women

International journal of cancer, 2009-11, Vol.125 (9), p.2166-2172

2009

Link zum Volltext

Verfügbarkeit prüfen

Anal Human Papillomavirus Testing with Digene’s Hybrid Capture 2 Using Two Different Sampling Methods

Diseases of the colon & rectum, 2008, Vol.51 (1), p.62-66

2008

Link zum Volltext

Verfügbarkeit prüfen

Expression Pattern and Subcellular Localization of Human Papillomavirus Minor Capsid Protein L2

The American journal of pathology, 2009, Vol.174 (1), p.136-143

2009

Link zum Volltext

Verfügbarkeit prüfen

Prevalence of anal HPV infection in solid‐organ transplant patients prior to immunosuppression

Transplant international, 2004-08, Vol.17 (7), p.366-369

2004

Link zum Volltext

Verfügbarkeit prüfen

A Virus-Like Particle Enzyme-Linked Immunosorbent Assay Detects Serum Antibodies in a Majority of Women Infected With Human Papillomavirus Type 16

JNCI : Journal of the National Cancer Institute, 1994-04, Vol.86 (7), p.494-499

1994

Link zum Volltext

Verfügbarkeit prüfen

Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition

Journal of Virology, 1996-05, Vol.70 (5), p.3298-3301

1996

Link zum Volltext

Verfügbarkeit prüfen

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

BMJ (Online), 1996-03, Vol.312 (7030), p.537

International edition, 1996

Link zum Volltext

Verfügbarkeit prüfen

Genital Human Papillomavirus Infection

Proceedings of the National Academy of Sciences - PNAS, 1994-03, Vol.91 (7), p.2436-2440

1994

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 35

Suche als RSS-Feed

Aktive Filter

SpracheDeutsch

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(31)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(34)
Humans
(32)
Life Sciences & Biomedicine
(30)
Biological And Medical Sciences
(20)
Medical Sciences
(19)
Adult
(15)
Human Papillomavirus
(14)
Papillomaviridae - Immunology
(13)
Infectious Diseases
(12)
Middle Aged
(12)
Animals
(11)
Cervical Cancer
(11)
Dermatology
(11)
Mice
(11)
Oncology
(11)
Antibodies, Viral - Blood
(10)
Papillomavirus Infections - Immunology
(10)
Tumors
(10)
Aged
(9)

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Chimeric L2-Based Virus-Like Particle (VLP) Vaccines Targeting Cutaneous Human Papillomaviruses (HPV)

A chimeric 18L1-45RG1 virus-like particle vaccine cross-protects against oncogenic alpha-7 human papillomavirus types

Attenuated Recombinant Influenza A Virus Expressing HPV16 E6 and E7 as a Novel Therapeutic Vaccine Approach

Seroreactivity to Cutaneous Human Papillomaviruses among Patients with Nonmelanoma Skin Cancer or Benign Skin Lesions

Impact of smoking on the quantity and quality of antibodies induced by human papillomavirus type 16 and 18 AS04-adjuvanted virus-like-particle vaccine - a pilot study

Developments in L2-based human papillomavirus (HPV) vaccines

RG2-VLP: a Vaccine Designed to Broadly Protect against Anogenital and Skin Human Papillomaviruses Causing Human Cancer

Efficacy of RG1-VLP Vaccination against Infections with Genital and Cutaneous Human Papillomaviruses

Human Papillomavirus 42 Drives Digital Papillary Adenocarcinoma and Elicits a Germ Cell-like Program Conserved in HPV-Positive Cancers

Cross-neutralizing protection of vaginal and oral mucosa from HPV challenge by vaccination in a mouse model

Establishment of an in vitro equine papillomavirus type 2 (EcPV2) neutralization assay and a VLP-based vaccine for protection of equids against EcPV2-associated genital tumors

Next generation polyphosphazene immunoadjuvant: Synthesis, self-assembly and in vivo potency with human papillomavirus VLPs-based vaccine

Cutaneous Human Papillomaviruses Found in Sun-Exposed Skin: Beta-papillomavirus Species 2 Predominates in Squamous Cell Carcinoma

Anogenital Human Papillomavirus Prevalence is Unaffected by Therapeutic Tumour Necrosis Factor-alpha Inhibition

High Prevalence of Cutaneous Human Papillomavirus DNA on the Top of Skin Tumors but not in “Stripped” Biopsies from the Same Tumors

A quadrivalent HPV vaccine induces humoral and cellular immune responses in WHIM immunodeficiency syndrome

Differences in incidence and co‐occurrence of vaccine and nonvaccine human papillomavirus types in Finnish population before human papillomavirus mass vaccination suggest competitive advantage for HPV33

Population dynamics of serologically identified coinfections with human papillomavirus types 11, 16, 18 and 31 in fertile‐aged Finnish women

Anal Human Papillomavirus Testing with Digene’s Hybrid Capture 2 Using Two Different Sampling Methods

Expression Pattern and Subcellular Localization of Human Papillomavirus Minor Capsid Protein L2

Prevalence of anal HPV infection in solid‐organ transplant patients prior to immunosuppression

A Virus-Like Particle Enzyme-Linked Immunosorbent Assay Detects Serum Antibodies in a Majority of Women Infected With Human Papillomavirus Type 16

Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition

Serologically diagnosed infection with human papillomavirus type 16 and risk for subsequent development of cervical carcinoma: nested case-control study

Genital Human Papillomavirus Infection

Aktive Filter

Suchergebnisse filtern